[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368020-105":59,"doc-detail-368020-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","cancer-burden-and-the-contributions-of-risk-factors-in-china-a-systematic-analysis-for-the-global-burden-of-disease-study-2021","Cancer burden and the contributions of risk factors in China - A systematic analysis for the Global Burden of Disease Study 2021","","China ranks among the world leaders in new cancer cases and deaths, making cancer burden assessment central for public health planning. This study evaluates cancer incidence, mortality, and risk-factor contributions using Global Burden of Disease Study (GBD) 2021 data. It quantifies new cases and deaths with 95% uncertainty intervals, estimates age-standardized incidence and death rate trends across multiple decades, and attributes outcomes to key risk factors.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-burden-and-the-contributions-of-risk-factors-in-china-a-systematic-analysis-for-the-global-burden-of-disease-study-2021/368020/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-burden-and-the-contributions-of-risk-factors-in-china-a-systematic-analysis-for-the-global-burden-of-disease-study-2021/368020.png","ImageObject",300,407,{"name":92,"@type":93},"dhado","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-20","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study?","Question",{"text":112,"@type":113},"To provide a detailed evaluation of cancer burden in China by examining incidence, mortality, and contributions from risk factors, using GBD 2021 data.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which datasets and time ranges were used for the estimates?",{"text":117,"@type":113},"Cancer incidence and mortality estimates use Global Burden of Disease Study (GBD) 2021. Trends include age-standardized incidence rates from 1990–2021 and age-standardized death rates from 1980–2021.",{"name":119,"@type":110,"acceptedAnswer":120},"What were the key findings for cancer burden in 2021?",{"text":121,"@type":113},"In 2021, China’s cancer burden included 13.66 million new cases and 2.82 million deaths. Age-standardized incidence and death rates were 790.2 and 137.5 per 100,000 population, respectively.",{"name":123,"@type":110,"acceptedAnswer":124},"Which risk factors and cancer sites were most prominent?",{"text":125,"@type":113},"Behavioral risks were linked to 73.57% of cancer deaths in 2021. Tracheal, bronchus, and lung cancer showed the highest age-standardized incidence among site-specific tumors.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},368020,1790455463,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":19,"preview_urls":149},5909893218464,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Original Article  \nCancer burden and the contributions of risk factors in China: A systematic analysis for the Global Burden of Disease Study 2021  \nZenghong Wu1, Suya Pang1, Yiqing Mei1, Chenyuan Qin2, Yang Jin3,4,5, Rong Lin1,6  \n1Division of Gastroenterology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430000, China;  \n2School of Public Health, Peking University, Beijing 100871, China;  \n3Department of Respiratory and Critical Care Medicine, Hubei Province Clinical Research Center for Major Respiratory Diseases, and NHC Key Laboratory of Pulmonary Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430000, China;  \n4Hubei Province Key Laboratory of Biological Targeted Therapy, MOE Key Laboratory of Biological Targeted Therapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430000, China;  \n5Hubei Province Engineering Research Center for Tumor-Targeted Biochemotherapy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430000, China;  \n6Hubei Province Engineering Research Center for Minimally Invasive Therapy of Digestive Disorders, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430000, China.  \nAbstract  \nBackground: As a populous country in the world, China ranks among the top in terms of new cancer cases and deaths worldwide. This study aims to provide a detailed evaluation of the cancer burden in China, considering the evolving social, economic, and environmental factors that may have influenced cancer incidence and mortality rates.  \nMethods: The cancer incidence, mortality, and the contributions of risk factors were estimated using data from the Global Burden of Disease Study (GBD) 2021. The number of new cases and deaths with their 95% uncertainty intervals (UIs) were analyzed. The trends of cancer age-standardized incidence rates (ASIR) from 1990 to 2021 and age-standardized death rates (ASDR) from 1980 to 2021 were estimated. Besides, risk factor contributions were also assessed.  \nResults: In 2021, the total burden of cancer in China comprised 13.66 million new cases (95% UI: 11.79 to 15.85 million) and 2.82 million deaths (95% UI: 2.35 to 3.36 million). In 2021, ASIR and ASDR of cancers were 790.2 (95% UI: 676.8–926.3) per 100,000 population and 137.5 (95% UI: 115.1–163.4) per 100,000 population, respectively. In 2021, tracheal, bronchus, and lung cancer showed the highest ASIR of 44.0 (95% UI: 35.4–53.3) per 100,000 population among site-specific tumors, followed by non-melanoma skin cancer (37.5 [95% UI: 32.4–42.7] per 100,000 population), colon and rectum cancer (31.4 [95% UI: 25.5–38.0] per 100,000 population), stomach cancer (29.1 [95% UI: 22.4–36.2] per 100,000 population), breast cancer (19.4 [95% UI: 15.0–24.3] per 100,000 population), esophageal cancer (15.0 [95% UI: 12–18.4] per 100,000 population), and liver cancer (9.5 [95% UI: 7.7–11.8] per 100,000 population) . Besides, the ASDR of cancers decreased about 29.78% in males and 42.00% in females in the past forty years in China. Tracheal, bronchus, and lung cancer showed the highest ASIR (62.63 per 100,000 population) and ASDR (56.45 per 100,000 population) in males. Of note, 31.73% of all cancer deaths in China were digestive cancers in 2021. For level 1 risks in 2021, behavioral risks were linked to 73.57% of cancer deaths.  \nConclusions: The disease burden of cancers remains a major public health concern in China. The ASIR increased from 1990 to 2021 and theASDR decreased from 1980 to 2021 in cancers. Tracheal, bronchus, and lung cancer remain the most common types of cancer in China.  \nKeywords: Cancer burden; China; Global Burden of Disease Study; Incidence; Mortality; Disability-adjusted life years; Trend  \nIntroduction  \nCancer is the second most common cause of death worldwide, and","cbCaicfe4d5SueGh","https://ap.wps.com/l/cbCaicfe4d5SueGh","pdf",2717291,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Cancer as a global health concern\n## Cancer transition in China","[{\"question\":\"What is the main goal of the study?\",\"answer\":\"To provide a detailed evaluation of cancer burden in China by examining incidence, mortality, and contributions from risk factors, using GBD 2021 data.\"},{\"question\":\"Which datasets and time ranges were used for the estimates?\",\"answer\":\"Cancer incidence and mortality estimates use Global Burden of Disease Study (GBD) 2021. Trends include age-standardized incidence rates from 1990–2021 and age-standardized death rates from 1980–2021.\"},{\"question\":\"What were the key findings for cancer burden in 2021?\",\"answer\":\"In 2021, China’s cancer burden included 13.66 million new cases and 2.82 million deaths. Age-standardized incidence and death rates were 790.2 and 137.5 per 100,000 population, respectively.\"},{\"question\":\"Which risk factors and cancer sites were most prominent?\",\"answer\":\"Behavioral risks were linked to 73.57% of cancer deaths in 2021. Tracheal, bronchus, and lung cancer showed the highest age-standardized incidence among site-specific tumors.\"}]","Cancer burden and the contributions of risk factors in China - A systematic analysis for the Global Burden of Disease Study 2021 | PDF",1790174395,23,[150,154,158,162],{"page_no":8,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/257c65c12b219d015a59cff589bbc8de.webp",983,1324,{"page_no":14,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ee735e2fc88859c17695dd381351f10.webp",982,1323,{"page_no":81,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8c94a0b70c37c283c2371fae2c3d2e0.webp",981,1321,{"page_no":19,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1c81c5af07c06d2ad8b2de1f3067b9fd.webp",980,1320]